Review
Endocrinology & Metabolism
Sarah H. H. Radi, Kiranmayi Vemuri, Jose Martinez-Lomeli, Frances M. M. Sladek
Summary: Since the purification and cloning of Hepatocyte Nuclear Factor 4 (HNF4a) more than 30 years ago, we have gained considerable insight into its role in liver function through its target genes and mouse experiments. HNF4a is a key player in lipid and glucose metabolism, and it intersects with diabetes, circadian rhythms, and liver cancer, although further research is needed to fully understand these interactions. While the isoforms expressed from its two promoters are being elucidated, little is known about the alternatively spliced variants in other regions of the protein and their impact on the 1000-plus HNF4a target genes.
FRONTIERS IN ENDOCRINOLOGY
(2023)
Article
Biochemistry & Molecular Biology
Takumi Kouketsu, Rina Monma, Yuri Miyairi, Shun Sawatsubashi, Hiroki Shima, Kazuhiko Igarashi, Akira Sugawara, Atsushi Yokoyama
Summary: This study investigates the interaction between HNF4α and IRF2BP2 and their regulatory effects on gluconeogenic gene expression. The experiments reveal that IRF2BP2 functions as a novel co-repressor of HNF4α, suppressing its transcriptional activity through its E3 ubiquitin ligase activity. This finding uncovers a new characteristic of nuclear receptor co-regulators.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
(2022)
Article
Gastroenterology & Hepatology
Sumedha Gunewardena, Ian Huck, Chad Walesky, Dakota Robarts, Steven Weinman, Udayan Apte
Summary: This study demonstrates that loss of HNF4 alpha activity is a crucial step in the pathogenesis of chronic liver diseases leading to hepatocellular carcinoma. Analysis of multiple datasets reveals a progressive reduction in HNF4 alpha activity with disease progression, associated with Child-Pugh class, decompensation, incidence of HCC, inflammatory changes, and survival.
Article
Biochemistry & Molecular Biology
Baharan Fekry, Aleix Ribas-Latre, Rachel Van Drunen, Rafael Bravo Santos, Samay Shivshankar, Yulin Dai, Zhongming Zhao, Seung-Hee Yoo, Zheng Chen, Kai Sun, Frances M. Sladek, Mamoun Younes, Kristin Eckel-Mahan
Summary: This study reveals the antagonistic effects of HNF4 alpha and BMAL1 in liver disease and HCC. Simultaneous loss of HNF4 alpha and BMAL1 protects against fatty liver and HCC. Furthermore, targeting BMAL1 expression in the absence of HNF4 alpha inhibits HCC growth and progression.
Review
Biochemical Research Methods
Jehison Alirio Herrera-Pulido, Francois-Michel Boisvert, Francois Boudreau
Summary: HNF4a is a master regulator gene involved in critical biological processes and has twelve distinct isoforms. However, little is known about the biological impact of each isoform and their mechanisms of transcription regulation. Proteomic analyses have identified proteins that interact with specific HNF4a isoforms, and the study of these interactions is important for understanding the role of this transcription factor in different biological processes and pathologies.
Article
Cell Biology
Xin Xu, Yidi Chen, Danyang Zhu, Tong Zhao, Rui Xu, Jiaying Wang, Lihong Hu, Xu Shen
Summary: This study identified a new non-steroidal GR antagonist named FX5 that effectively improved glucose homeostasis in T2DM mice by suppressing gluconeogenesis genes and antagonizing GR, highlighting its potential in T2DM treatment.
Article
Biochemistry & Molecular Biology
Qiang Liu, Xiaohua Lei, Zhenyu Cao, Ju Zhang, Likun Yan, Jie Fu, Qing Tong, Wei Qin, Yaoli Shao, Chun Liu, Zhiqiang Liu, Zicheng Wang, Yuan Chu, Ge Xu, Siyuan Liu, Xueyi Wen, Hirofumi Yamamoto, Masaki Mori, Xin M. Liang, Xundi Xu
Summary: The study suggests that TRPM8 may have a protective effect against fibrosis by combating inflammation, cholangiopathies, and fibrosis progression through the S100A9-HNF4 alpha signaling pathway. TRPM8 deficiency in mice showed reduced inflammation and fibrosis progression, as well as alleviation of symptoms related to cholangiopathies.
CELL AND BIOSCIENCE
(2022)
Review
Oncology
Aamir Salam Teeli, Kamila Luczynska, Effi Haque, Mohmmad Abrar Gayas, Dawid Winiarczyk, Hiroaki Taniguchi
Summary: Liver cancer is a deadly disease with hotspot mutations in HNF4 alpha and HNF1 alpha. These transcription factors play crucial roles in maintaining tissue homeostasis and have been identified as important therapeutic targets in liver cancer treatment. Their dysregulation can lead to tumorigenesis and personalized medicine approaches are being developed to target them for liver cancer therapy.
Article
Endocrinology & Metabolism
Sandra Tobon-Cornejo, Ariana Vargas-Castillo, Alekxa Leyva-Martinez, Victor Ortiz, Lilia G. Noriega, Laura A. Velazquez-Villegas, Gabriela Aleman, Janette Furosawa-Carballeda, Nimbe Torres, Armando R. Tovar
Summary: The study found that PPARα plays a key role in inhibiting the activity of HNF4α, thereby affecting liver amino acid catabolism. This regulatory process is influenced by the amount of protein intake and is controlled by RXRα.
METABOLISM-CLINICAL AND EXPERIMENTAL
(2021)
Article
Endocrinology & Metabolism
Toshiharu Onodera, Dae-Seok Kim, Risheng Ye, May-Yun Wang, Shiuhwei Chen, Bianca C. Field, Leon Straub, Xue-Nan Sun, Chao Li, Charlotte Lee, Megan Paredes, Clair Crewe, Shangang Zhao, Christine M. Kusminski, Ruth Gordillo, Philipp E. Scherer
Summary: The disease progression of metabolic syndrome is associated with the role of adiponectin in pancreatic islets, which maintains normal pancreatic function by regulating the expression of the transcription factors PPARa and HNF4a.
MOLECULAR METABOLISM
(2023)
Article
Chemistry, Medicinal
Cole Emanuelson, Nicholas Ankenbruck, Rohan Kumbhare, Meryl Thomas, Colleen Connelly, Yasmine Baktash, Glenn Randall, Alexander Deiters
Summary: A new class of small-molecule miR-122 inhibitors has been discovered, which significantly reduces HCV replication in human liver cells, indicating their potential therapeutic importance.
JOURNAL OF MEDICINAL CHEMISTRY
(2022)
Article
Gastroenterology & Hepatology
Christine Jones, Mariano Avino, Veronique Giroux, Francois Boudreau
Summary: Transcriptomic analysis revealed the crucial role of HNF4 alpha in supporting the growth and survival of jejunal enteroids, as well as its autonomous function in Wnt3 transcriptional regulation and Paneth cell differentiation.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY
(2023)
Review
Medicine, Research & Experimental
Ningxin Qu, Ting Luan, Naiquan Liu, Chenhui Kong, Le Xu, Hong Yu, Ye Kang, Ye Han
Summary: HNF4 alpha, a transcription factor, plays a vital role in regulating functional genes and biological processes. Aberrant expression of HNF4 alpha is associated with tumor progression and metastasis, potentially by affecting downstream target genes and signaling pathways.
BIOMEDICINE & PHARMACOTHERAPY
(2023)
Article
Multidisciplinary Sciences
Abigail E. Loneker, Farid Alisafaei, Aayush Kant, David Li, Paul A. Janmey, Vivek B. Shenoy, Rebecca G. Wells
Summary: Matrix stiffening and external mechanical stress have been found to be linked to disease and cancer development. In this study, researchers treated human hepatocytes with oleate and found that lipid droplets are intracellular mechanical stressors, causing nuclear deformation, chromatin condensation, and impaired hepatocyte function.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
(2023)
Article
Gastroenterology & Hepatology
Jiyun Ahn, Hyunjung Lee, Chang Hwa Jung, Seung Yeon Ha, Hyo-Deok Seo, Young In Kim, Taeyoul Ha
Summary: The study demonstrates that miR-467b-3p is down-regulated in liver tissues of high-fat diet-fed mice and FFA-treated Hepa1-6 cells. Overexpression of miR-467b-3p reduces intracellular lipid accumulation and mitigates hepatic steatosis. 6-G upregulates miR-467b-3p and improves NAFLD through the HNF4 alpha/miR-467b-3p/GPAT1 cascade.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY
(2021)
Article
Endocrinology & Metabolism
Sadia Saeed, Qasim M. Janjua, Attiya Haseeb, Roohia Khanam, Emmanuelle Durand, Emmanuel Vaillant, Lijiao Ning, Alaa Badreddine, Lionel Berberian, Mathilde Boissel, Souhila Amanzougarene, Mickael Canouil, Mehdi Derhourhi, Amelie Bonnefond, Muhammad Arslan, Philippe Froguel
Summary: Recent advances in genetic analysis have helped understand the genetic basis of obesity, specifically the disruption of melanocortin signaling by monogenic variants. In this study, rare variants in obesity-causing genes were assessed in young adults with severe obesity from Pakistan. Thirteen subjects were found to carry pathogenic variants in different obesity-related genes, including two homozygous stop-gain mutations in previously unreported genes. Homozygous mutations and copy-loss CNVs in genes previously linked to obesity were also identified. Notably, pathogenic mutations in LEP and LEPR were rarely found in this cohort of young adults, possibly due to differences in morbidity and social disadvantage compared to obese children.
Article
Endocrinology & Metabolism
Elmar W. Tobi, Diana L. Juvinao-Quintero, Justiina Ronkainen, Raffael Ott, Rossella Alfano, Mickael Canouil, Madelon L. Geurtsen, Amna Khamis, Leanne K. Kupers, Ives Y. Lim, Patrice Perron, Giancarlo Pesce, Johanna Tuhkanen, Anne P. Starling, Toby Andrew, Elisabeth Binder, Robert Caiazzo, Jerry K. Y. Chan, Romy Gaillard, Peter D. Gluckman, Elina Keikkala, Neerja Karnani, Sanna Mustaniemi, Tim S. Nawrot, Francois Pattou, Michelle Plusquin, Violeta Raverdy, Kok Hian Tan, Evangelia Tzala, Katri Raikkonen, Christiane Winkler, Anette-G Ziegler, Isabella Annesi-Maesano, Luigi Bouchard, Yap Seng Chong, Dana Dabelea, Janine F. Felix, Barbara Heude, Vincent W. V. Jaddoe, Jari Lahti, Brigitte Reimann, Marja Vaarasmaki, Amelie Bonnefond, Philippe Froguel, Sandra Hummel, Eero Kajantie, Marjo-Riita Jarvelin, Regine P. M. Steegers-Theunissen, Caitlin G. Howe, Marie-France Hivert, Sylvain Sebert
Summary: Maternal hyperglycemia is associated with lower cord blood DNAm at TXNIP, and these CpGs may be candidate loci for future causal and mediation analyses.
Article
Endocrinology & Metabolism
Prapaporn Jungtrakoon Thamtarana, Antonella Marucci, Luca Pannone, Amelie Bonnefond, Serena Pezzilli, Tommaso Biagini, Patinut Buranasupkajorn, Timothy Hastings, Christine Mendonca, Lorella Marselli, Rosa Di Paola, Zuroida Abubakar, Luana Mercuri, Federica Alberico, Elisabetta Flex, Julian Ceron, Montserrat Porta-de-la-Riva, Ornella Ludovico, Massimo Carella, Simone Martinelli, Piero Marchetti, Tommaso Mazza, Philippe Froguel, Vincenzo Trischitta, Alessandro Doria, Sabrina Prudente
Summary: This study identified mutations in the MDH2 gene that are associated with familial forms of diabetes. These mutations affect the structure and function of the MDH2 protein. They increase the enzymatic activity of MDH2, leading to a decrease in the NAD+/NADH ratio and affecting insulin signaling and secretion. This study suggests that gain of function variants in the MDH2 gene may play a role in the etiology of familial forms of diabetes.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
(2022)
Article
Chemistry, Physical
Bilal Demir, Lea Rosselle, Anna Voronova, Quentin Pagneux, Audrey Quenon, Valery Gmyr, Dorothee Jary, Nathalie Hennuyer, Bart Staels, Thomas Hubert, Amar Abderrahmani, Valerie Plaisance, Valerie Pawlowski, Rabah Boukherroub, Severine Vignoud, Sabine Szunerits
Summary: Through engineering non-dissolving microneedle arrays and incorporating MoS2 nanosheets as a photothermal component into hydrogels, on-demand release of macromolecular therapeutic drugs such as insulin has been achieved for skin penetration and therapeutic purposes. This system successfully reduced blood glucose levels in mice and pigs, potentially altering current insulin therapies.
NANOSCALE HORIZONS
(2022)
Article
Multidisciplinary Sciences
Oihane Garcia-Irigoyen, Fabiola Bovenga, Marilidia Piglionica, Elena Piccinin, Marica Cariello, Maria Arconzo, Claudia Peres, Paola Antonia Corsetto, Angela Maria Rizzo, Marta Ballanti, Rossella Menghini, Geltrude Mingrone, Philippe Lefebvre, Bart Staels, Takuji Shirasawa, Carlo Sabba, Gaetano Villani, Massimo Federici, Antonio Moschetta
Summary: This study provides compelling evidence supporting the involvement of oxidative stress and intestinal inflammation in obesity and its related comorbidities. The deficiency of the antioxidant enzyme SOD2 in the gastrointestinal tract leads to spontaneous obesity in mice. This obesity phenotype is driven by PLA2 activation and increased release of arachidonic acid. The negative correlation between intestinal SOD2 mRNA levels and obesity features is conserved between mice and humans, suggesting potential therapeutic targets for this metabolic disorder.
Review
Biochemistry & Molecular Biology
Fanny Lassalle, Mickael Rosa, Bart Staels, Eric Van Belle, Sophie Susen, Annabelle Dupont
Summary: Transcatheter aortic valve replacement (TAVR) has revolutionized the treatment of severe aortic valve stenosis (AVS) and is considered an alternative to open heart surgery. TAVR has shown good prognosis for patients, but is still associated with postprocedural complications like bleeding or thrombosis. This study aimed to provide a comprehensive overview of the impact of TAVR on monocyte phenotype and subset distribution and their association with clinical outcomes in patients with severe AVS who underwent TAVR.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2022)
Article
Endocrinology & Metabolism
Lucas Fajardo, Phelipe Sanchez, Jerome Salles, Jean Paul Rigaudiere, Veronique Patrac, Sylvie Caspar-Bauguil, Camille Bergoglgio, Cedric Moro, Stephane Walrand, Olivier Le Bacquer
Summary: Inhibition of the endocannabinoid system (ECS) by RIM (10 mg/kg/day) was effective in reducing body fat and improving muscle function in obese aged mice.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
(2023)
Article
Nutrition & Dietetics
Marion Courtalin, Helene Verkindt, Naima Oukhouya Daoud, Nassima Ramdane, Bernard Cortet, Francois Pattou, Julien Paccou
Summary: The study aimed to evaluate the implementation of the ECTS 2022 recommendations for preventing and treating osteoporosis after bariatric surgery. A retrospective cohort study was conducted on postmenopausal women and men aged 50 and older who had undergone or were undergoing bariatric surgery. Osteoporosis medication was indicated if certain criteria were met, and a fifth of the population surveyed was found to be eligible.
Article
Medicine, General & Internal
Amelie Bonnefond, Ranjit Unnikrishnan, Alessandro Doria, Martine Vaxillaire, Rohit N. Kulkarni, Viswanathan Mohan, Vincenzo Trischitta, Philippe Froguel
Summary: Monogenic diabetes encompasses several clinical conditions characterized by early-onset diabetes, including neonatal diabetes, maturity-onset diabetes of the young (MODY) and diabetes-associated syndromes. It can be misdiagnosed as type 2 diabetes, and different genetic variations can lead to different forms of diabetes. Precision medicine approaches and next-generation sequencing have improved diagnosis and treatment options.
NATURE REVIEWS DISEASE PRIMERS
(2023)
Article
Cell Biology
Clement Philippe Delannoy, Egon Heuson, Adrien Herledan, Frederik Oger, Bryan Thiroux, Mickael Chevalier, Xavier Gromada, Laure Rolland, Philippe Froguel, Benoit Deprez, Sebastien Paul, Jean-Sebastien Annicotte
Summary: Type 2 diabetes is a metabolic disorder affecting over 537 million people worldwide, characterized by loss of pancreatic beta-cell function and insulin resistance. Long-term control of glycemia is challenging, highlighting the need for new drugs and targets to improve beta-cell function and insulin secretion. In this study, a high-throughput screening method using automated cellular assays and mass spectrometry was developed, identifying potential regulators of insulin secretion and synthesis among siRNA and chemical compounds.
Article
Cell Biology
Yasmina Kahoul, Xi Yao, Frederik Oger, Maeva Moreno, Souhila Amanzougarene, Mehdi Derhourhi, Emmanuelle Durand, Raphael Boutry, Amelie Bonnefond, Philippe Froguel, Christian Dani, Jean-Sebastien Annicotte, Christophe Breton
Summary: Human induced pluripotent stem cells (hiPSCs) have the potential to differentiate into any cell type, making them relevant for therapeutic applications. In particular, they hold promise for obesity treatment by providing an unlimited source of brown/beige adipose progenitors (hiPSC-BAPs). However, the limited differentiation potential of brown/beige adipocytes in 2D cultures poses a challenge for clinical use.
Article
Endocrinology & Metabolism
Lise Folon, Morgane Baron, Benedicte Toussaint, Emmanuel Vaillant, Mathilde Boissel, Victoria Scherrer, Helene Loiselle, Audrey Leloire, Alaa Badreddine, Beverley Balkau, Guillaume Charpentier, Sylvia Franc, Michel Marre, Soulaimane Aboulouard, Michel Salzet, Mickael Canouil, Mehdi Derhourhi, Philippe Froguel, Amelie Bonnefond
Summary: Rare biallelic pathogenic mutations in PCSK1 cause early-onset obesity and other endocrinopathies. Functional genomic study shows that rare heterozygous variants of PCSK1 can also impact obesity risk.
LANCET DIABETES & ENDOCRINOLOGY
(2023)
Meeting Abstract
Endocrinology & Metabolism
Sadia Saeed, Jaida Manzoor, Roohia Khanam, Qasim Janjua, Lijiao Ning, Hina Ayesha, Waqas Khan, Amelie Bonnefond, Sharoon Hanook, Taeed Butt, Muhammad Arslan, Philippe Froguel
HORMONE RESEARCH IN PAEDIATRICS
(2022)
Meeting Abstract
Genetics & Heredity
Igor Pupko, Ayse Demirkan, Liudmila Zudina, Zhanna Balkhiyarova, Anna Ulrich, Vincent Pascat, Jared Maina, Philippe Froguel, Marika Kaakinen, Inga Prokopenko
GENETIC EPIDEMIOLOGY
(2022)
Meeting Abstract
Endocrinology & Metabolism
S. Meulebrouck, M. Canouil, M. Derhourhi, B. Balkau, G. Charpentier, S. Franc, M. Michel, R. Roussel, M. Vaxillaire, P. Froguel, A. Bonnefond